About

Dietmar Berger is Gilead's Chief Medical Officer, responsible for the company's virology, oncology and inflammation pipeline and its global development and medical affairs organizations. A board-certified internist, hematologist and oncologist with more than 25 years of experience, he previously served as Senior Vice President and Global Head of Development at Sanofi from 2019 to 2024 and, before that, as EVP and Global Head of R&D at Atara Biotherapeutics.

Roles

Gilead Sciences, Inc.
Chief Medical Officer · Current role
2025–present

Also at Gilead Sciences, Inc.

Related

See how Top Bucket AI works for your firm

Request Demo
Top Bucket AI Research

Stay ahead of private markets

Research and market intelligence for private-markets professionals.

✓

You're subscribed.

Thanks for signing up.